Objective: To prospectively validate performance of a prediction score for diagnosis of late-onset neonatal sepsis (LNS) in a new patient population. Result: A total of 105 neonates were evaluated for sepsis. Demographic characteristics were as follows: (mean (s.d.)) were gestational age (GA) 29 (3) weeks; birth weight (BW) 1232 (620) g and postnatal age 17.5 day (12). Thirty-five (33%) neonates had LNS (35 positive blood cultures; 2 positive CSF). No significant differences in GA, BW, gender, age and central line utilization were found between LNS positive and LNS negative groups. Using a cut-off score of p3, the score predicted positive culture with sensitivity of 0.97 (95% confidence interval 0.85, 0.99) and a negative likelihood ratio of 0.07. The discrimination and calibration ability of LNS score was acceptable.
Introduction
Nosocomial infection or late-onset neonatal sepsis (LNS) remains a significant cause of mortality and morbidity in neonates. Recent evidence suggests only a limited accuracy of the single hematologic and C-reactive protein testing for the diagnosis of infections in neonates. 1, 2 It has been proposed that new and more sophisticated laboratory tests, including interleukins (IL)-6, IL-8 and procalcitonin, would enable diagnosis of LNS at an increasingly earlier stage. 3, 4 However, the reliability of these tests are questionable, which require further evaluation in much larger patient populations. In addition, in clinical settings with limited resources, such tests are not available or impracticable, or remain expensive for routine neonatal care. 5 As a consequence, clinical management still largely relies on the combination of clinical signs, potential risk factors and complete blood count (CBC). This approach currently guides presumptive diagnosis and management decision. We developed a prediction tool for diagnosis of LNS, composed of four clinical parameters and two hematologic parameters as follows: hypotension, temperature abnormality, respiratory insufficiency, band count >1%, platelet count <150 000/ml 3 , and the use of umbilical venous catheters (UVC) between 1 and 7 days or >7 days. 6 In our original description, the LNS score yielded a good diagnostic performance with an area under the receiver-operating characteristics curve (AUC) of 0.8. 6 The LNS scores were derived from a retrospective cohort of 1817 neonates. We used coefficients derived from Cox proportional hazard models to compose the scoring rule. We then validated the clinical prediction score in 73 neonates in the same hospital who were evaluated for sepsis. 6 The scaling of the prediction score is shown in Table 1 .
The performance of a clinical prediction rule drawn from a single study may be misleading. To assess generalizability, external validation in an entirely different population is needed. 7, 8 Therefore, the objective of this study was to validate the LNS score performance in a different neonatal intensive care unit (NICU), and indeed in a different country.
Methods
The study was conducted at a level-III NICU at McMaster Medical Center in Ontario, Canada; and was designed as a prospective cohort study. This study was a part of a multicenter protocol primarily intended to evaluate the use of procalcitonin and the NOSEP score 9 in the prediction of nosocomial sepsis in NICU. Data from only one unit were used, as other centers are in process of recruitment and data collection. All parts of the protocol were approved by McMaster Research Ethics Board.
The inception cohort consisted of neonates aged 2 to 90 days, who had been inpatients in the NICU for more than 48 h; and where caregivers had decided to embark upon a 'sepsis' diagnostic workup, during the first evaluation of sepsis. Term infant who was older than 28 days, and preterm infant whose corrected age was greater than 28 days, were excluded. The exclusion criteria were (1) receipt of antibiotics before the septic screen and (2) the infant had been previously discharged home.
All clinicians who made clinical decisions regarding sepsis (fellows, residents and clinical nurse specialists (CNS)) were asked to complete a questionnaire on the clinical indications that led them to perform a septic screen. They were also asked to rate the probability of true sepsis on a scale of 1 to 10 after obtaining basic laboratory results. CBC, including band count, was performed using an automated system. One sample of blood culture was obtained by a clinically mandated venepuncture, during which a minimum of 0.5 ml of blood culture volume was drawn. Following unit policy, cerebrospinal fluid (CSF) culture and urine culture were only selectively collected by decision of the attending clinician. Data on age, gender, birth weight, gestational age, chronic lung disease, ventilation, surgeries, previous infections, length of stay before infection evaluation, type of central venous catheter (CVC), site of CVC, duration of CVC in place were recorded. The types of CVC included UVC, umbilical arterial catheters, peripheral inserted central catheter (PICC) and Broviac catheters. Prescription of antibiotics was recorded as type, duration and action after physicians obtained culture results. Information about severity of illness at the time of sepsis evaluation was not collected.
Clinicians ordering the tests were not aware of the criteria for the LNS score, and the score was calculated without knowledge of culture results. The criterion standard for the presence of an LNS was either a positive blood culture or CSF culture. Blood culture was performed on every sepsis evaluation. CSF and urine culture were performed selectively and depended on clinicians' judgment. For the purpose of our study, a positive culture was defined as contamination, if the attending clinicians ignored the positive culture, and discontinued antibiotics therapy, but there was no adverse effect on infants. Routine second cultures were not part of this unit policy.
Statistical analysis
Demographic characteristics of studied infants were presented in percentage, mean (s.d.) or median (inter-quartile range). The w 2 -test, t-test and Mann-Whitney test were used, and P<0.05 was considered statistically significant.
The LNS score as obtained from the original study was applied to the current data without modification. We estimated the distribution of patients across the categories of the score, to enable quantification of the predictive values per scoring category.
We assessed the diagnostic or discrimination ability of the clinical prediction score using the AUC with 95% confidence interval (CI). The AUC is the probability of concordance between outcomes and predictions. In this study, it represents the probability that a randomly chosen neonate with LNS will have a higher predicted score than a randomly chosen neonate without LNS. 10 Prediction scores are typically acceptable if its AUC exceeds 0.7. 11 The calibration ability or precision is the ability to produce unbiased estimates of the probability of outcome. We assessed calibration ability using both graphical plotting and the Hosmer-Lameshow goodness of fit (H-L) test. The H-L test assesses agreement between predicted and observed probability, in which P-values of <0.1 indicate significant disagreement. All statistical analysis was performed using STATA statistical software release 9.2 (StataCorp, College Station, TX, USA). Table 2 . There were no significant There were 35 neonates (33%) with either a positive blood culture or positive CSF culture. Nineteen lumbar punctures were performed. None of the positive blood or CSF culture results were considered as contaminant by the responsible clinicians. The pathogens responsible for LNS are presented in Table 3 . The majority of pathogens were coagulase-negative Staphylococci (CONS). Two CSF cultures were positive: one was Bacillus cereus and one was CONS. Both infants also had positive blood cultures for the same organism, at the same time.
Results

During
The incidence of LNS in each score cluster is presented in Table 4 . In design of our scale, we had defined a score of 3 as a cutoff that discriminate between neonates with 'low risk' of LNS and 'medium' to 'high risk' of LNS. Application of this score to neonates in the current study, however, misclassified one neonate with LNS with a score of 2; all other neonates with LNS (n ¼ 34) had a clinical score of 4 or higher. The only neonate who was misclassified had a CONS septicemia. This was a 30-week, 14-day neonate without a CVC. The recorded indication for performing of sepsis evaluation in this neonate was an abnormal white blood cell count from a 'routine' CBC check. Despite absence of clinical signs, this neonate was treated with vancomycin for 10 days. No quantitative or repeat blood culture was performed on this neonate. We have tried to modify the LNS score by incorporating utilization of all CVCs instead of only UVC, but the performance of the modified LNS score was poorer with AUC of 0.73.
The AUC of the LNS score in the current study was 0.78 (95% CI 0.068, 0.87), which was comparable with the original study (AUC 0.80; 95% CI 0.69, 0.90) (P ¼ 0.8). The comparison of data from the original study (internal validation), with this current study (external validation), is presented in Table 4 . There was no obvious difference between both studies in terms of the study characteristics and test performance. As presented in Table 5 , with the cut-off value of the score p3, the sensitivity was 0.97 (95% CI 0.85, 0.99) with the corresponding negative likelihood ratio (LRÀ) of 0.07 and negative predictive value of 0.97. With a cut-off value of the score X8, the specificity was 0.98 (95% CI 0.92, 0.99) with the corresponding positive likelihood ratio (LR þ ) of 14 and External validation of prediction score for LNS C Okascharoen et al positive predictive value of 0.88. Within the gray zone of the score 4 to 7, the performance of score was poorer with the sensitivity of 0.77 and specificity of 0.43. There were 83 caregivers (79%) who rated the probability that the infant they were investigating had a true LNS. These were composed of 19 residents (23%), 19 fellows (23%), 45 CNS (54%). Clinicians' rating on the probability of LNS yielded an AUC of 0.82 (95% CI 0.74 to 0.90). There was no significant difference of AUC among the groups of clinicians (P ¼ 0.8). The receiver-operating characteristic curve analysis showed there was no significant difference between our prediction score and the clinicians' own rating of probability of true LNS (P ¼ 0.3). However, the graphical plots of calibration are presented in Figures 1 and 2 . This shows that the calibration of LNS score was good, (Figure 1 ) and yields a H-L test P-value of 0.62. In comparison to the LNS score, the calibration curve of clinician's prediction was considerably below the dotted ideal line. This suggests a trend to overestimate the probability of LNS (Figure 2 ), but H-L test P-value was 0.28. It appears from this analysis that the LNS score may be superior to the performance of the clinician rating. Antibiotic therapy was initiated in 94/105 (89%) neonates who were suspected of having sepsis. Sixty-two of 94 treated neonates (66%) were later classified as LNS negative. Three of 11 neonates (27%) who did not initially receive antibiotics therapy were later classified as LNS positive. All of these three had positive blood culture with CONS, and all received antibiotic treatment after positive culture results.
Discussion
We have prospectively evaluated a previously derived clinical prediction score in an entirely different setting. We found the performance of the LNS score determined by the AUC was acceptable and comparable with the internal validation study (n ¼ 73). 6 In contrast to the external validation study of the NOSEP score, 9 the AUC of the LNS score was comparable to the AUC of the original study, without any need for a modification of the LNS score. Hui et al. 12 reported performance of procalcitonin testing for diagnosis of LNS in the same study population elsewhere. At cut-off value of 0.4 ng/ml, procalcitonin sensitivity was 0.91 (95% CI 0.73, 0.99), specificity was 0.43 (95% CI 0.28, 0.59), and AUC was 0.78 (95% CI 0.67, 0.89).
All of the neonates in this study were admitted to a tertiary care NICU and all of the sepsis events were nosocomial infections. We only examined the diagnosis of infection in the first sepsis evaluation, in order to avoid problems of positive results related to previous sepsis episodes, and to avoid multiple readings from the same infants. These requirements ensure that our criterion standard of positive cultures would truly detect LNS. We realize that including only the culture-proven infection possibly resulted in underestimation of incidence of LNS. However, including clinical-suspected LNS as reference standard, which is depended on subjective assessment, is likely to produce overestimation of the test performance as clearly illustrated by Lijmer et al. 13 In this NICU, reported incidence of urinary tract infection was 7.9%, but was associated with urinary catheterization in which it is seldom used in our setting.
14 Currently, there is no established criterion for Hosmer-Lemshore test p -value=0.28 Figure 2 Calibration curve of clinicians' prediction. 3% (1) 40% (27) 87% (7) blood culture contamination in neonates. 15 Quantitative blood culture is not usual in clinical settings, and a duplicate sample for blood culture would entail further venepunture. In this NICU, this was not a standard procedure. Instead, we used clinicians' judgment and the clinical course as a criterion for contamination. We acknowledge that this is not perfect, however when a clinician prefers to continue to treat, this may indicate serious clinical suspicion. The majority of sepsis events in this cohort were CONS. This may be a potential limitation of the instrument to situations where different floras are more widespread. However, for now it remains in western units the commonest cause of sepsis in newborn.
We used AUC as the index of discrimination of the LNS score, and as a means to compare the original study with the current study. In expressing the practical interpretation of AUC, the LNS score has a probability of 0.78 in accurate discrimination between LNS negative and LNS positive. 10 There was no significant difference between the AUC of prediction score and clinicians' estimation of LNS. Similar results were reported by Fischer, 16 who found that physicians' ability to estimate serious infection in pediatric patients (including neonates) yielded an AUC of 0.88. In Fischer's sample, there were 205 newborns and 142 children with sepsis, and the setting of their study was also a tertiary care one. However, the clinician's estimation of LNS in our setting was likely to be teams' opinion rather than individual estimation.
As presented in Figures 1 and 2 , the plot of the calibration curve suggests that clinicians tend to overestimate the probability of LNS. Although the P-value of H-L test of clinicians' prediction was >0.1, the small sample size (n ¼ 89) might yield a false negative result. Hence, it is still possible that the use of this LNS score quantifies and systematized a clinician's estimation of the probability of LNS. This might explain why there was no difference in AUC between LNS score and the clinician's estimation of true LNS in our study. Adopting the clinical prediction score might assist an objective assessment of neonate with sepsis suspicion, especially by trainees. This could be particularly helpful for clinical care settings with limited access to experienced specialist advice, such as in primary care; or secondary care which newborns are cared by general pediatricians. The current cost of the newer diagnostic technologies, for instance procalcitonin, might make this a potentially cost-effective tool in some health-care settings. However, this potential benefit needs further evaluation.
In our original study, we defined the risk of LNS based on a probability estimated by logistic regression analysis of either 'low' (probability of LNS ¼ 0.1), 'medium' (probability ¼ 0.4) or 'high' (probability ¼ 0.7). 6 The suggested cut-off value of 3 was based on test performance and the estimated probability. The observed prevalence of LNS in this study showed the same pattern of risk classified by the LNS score. Use of the LNS score is straightforward, and the required information is readily obtainable at bedside. The interpretation of LNS score is similar to interpretation of usual laboratory test. In terms of application, this clinical predictive score provides a good illustration of simple 'rule-in' and 'rule-out rules'. 17 It is generally accepted that in rule-in disease, a test with a high specificity or a LR þ >10 is needed, while a test with a high sensitivity or a LRÀ <0.1 is required to rule-out disease. The LNS score of 3 (LRÀ ¼ 0.07) will rule out LNS, while a score of 8 (LR þ ¼ 14) will rule in LNS. For a score of 4 to 7, the performance of LNS score was less clear, but we suggest continue to rule-in LNS because the prevalence of LNS in this score range was 0.4.
We found no association between utilization rates of CVCs other than UVC and LNS. Studies by Liossis et al. 18 and Parellada et al.
19
also showed the same direction of association between using PICC line and catheter-related infection in neonates comparing to peripheral intravenous line. However, the results in this study were limited to only first episode of sepsis evaluation. It is possible that this explains the present findings which are in contrast to studies showing CVCs are potential sources of LNS. 20 Incorporating utilization of all CVCs into the prediction score yielded poorer performance. While the length of usage of the UVC is recommended by the CDC to be less than 10 days, 21 a recent randomized controlled trial could not endorse this finding. 22 Regarding potential bias, we used a consecutive cohort of clinical population and culture-proven infection as reference standard. Therefore, it was unlikely that we overestimated the LNS score predictive performance. 13 However, the clinical outcomes, safety and costs of implementation of the LNS score were not assessed in this study. The addition of test laboratory parameters such as CRP or procalcitonin might further aid the LNS score. In underdeveloped countries where laboratory testing is still considered expensive, the LNS might still be of benefit however, in the absence of further lab testing.
Conclusion
The LNS score, combining clinical and simple hematology values, showed a stable and acceptable predictive performance. We are unable to comment on the cost savings this might institute. It is likely that the score would systematize the immature clinician's experience, in order to make clinical diagnosis easier. The utility of this, especially in resource-poor areas, is yet to be tested. Impacts of adopting the LNS score into routine neonatal practice still need further evaluation in term of clinical outcomes, and economic savings. This is particularly the case for units where the resident flora might more regularly include a broader array of differing organisms.
